Joseph R Young Vera Therapeutics, Inc. (VERA) insider trading activity

Joseph R Young is SVP, FINANCE, CHIEF ACCT OFFCR of Vera Therapeutics, Inc.. Currently has a direct ownership of 57,839 shares of VERA, which is worth approximately $1.64 Million. The most recent transaction as insider was on Nov 13, 2025, when has been sold 10,000 shares (Class A Common Stock) at a price of $3.94 per share, resulting in proceeds of $39,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.8K

6.63% 3M change

12.95% 12M change

Total Value Held $1.64 Million

Joseph R Young Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 13 2025	BUY Exercise of conversion of derivative security	$39,400 $3.94 p/Share	10,000 Added 14.74%	57,839 Class A Common Stock
Nov 11 2025	SELL Open market or private sale	$435,900 $29.06 p/Share	15,000 Reduced 23.87%	47,839 Class A Common Stock
Feb 18 2025	BUY Grant, award, or other acquisition	-	10,740 Added 14.78%	61,946 Class A Common Stock
May 16 2024	SELL Open market or private sale	$880,352 $42.63 p/Share	20,651 Reduced 28.74%	51,206 Class A Common Stock
May 16 2024	BUY Exercise of conversion of derivative security	$162,523 $7.87 p/Share	20,651 Added 27.77%	53,706 Class A Common Stock
May 15 2024	SELL Open market or private sale	$432,090 $42.42 p/Share	10,186 Reduced 16.59%	51,206 Class A Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	$32,390 $3.94 p/Share	8,221 Added 11.81%	61,392 Class A Common Stock

Apr 10 2024	SELL Open market or private sale	$228,560 $40.0 p/Share	5,714 Reduced 9.7%	53,171 Class A Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	-	21,875 Added 27.71%	57,054 Class A Common Stock
Jul 05 2023	BUY Exercise of conversion of derivative security	$39,400 $3.94 p/Share	10,000 Added 23.43%	32,679 Class A Common Stock
Aug 19 2022	BUY Grant, award, or other acquisition	-	15,000 Added 48.16%	16,148 Class A Common Stock
Feb 06 2022	BUY Open market or private purchase	$39,998 $7.0 p/Share	5,714 Added 20.12%	22,679 Class A Common Stock

JRY

Joseph R Young

SVP, FINANCE, CHIEF ACCT OFFCR

Brisbane, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERA shares.

Notify only if

Value

Insider Trading

Get notified when an Vera Therapeutics, Inc. insider buys or sells VERA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vera Therapeutics, Inc.

Track Activities on VERA

Account